RA Capital Management is a Boston-based investment management firm specializing in growth-oriented and early-stage support for healthcare, life sciences, and planetary health companies. The company deploys capital across private seed rounds, series financings, and public markets, with a focus on drugs, medical devices, diagnostics, and tools that advance patient care. It leverages a science-driven approach through its research platform TechAtlas and provides value-added services such as board representation, executive recruitment, and market intelligence to portfolio companies. The firm operates an incubator program called Raven to nurture biomedical innovation and maintains an Innovator Resources program to guide company development. RA Capital emphasizes evidence-based investing, long-term partnerships, and social responsibility, aiming to drive value creation from inception through commercialization.

MassVentures is a Massachusetts-based venture capital firm that provides seed and early-stage funding to high-growth startups in the Massachusetts innovation economy, helping concepts move from idea to commercialization. Founded in 1978 as a quasi-public corporation by the Legislature of the Commonwealth, it is governed by an independent board and managed by experienced venture investors. The firm focuses on information technology, healthcare, cybersecurity, e-commerce, mobile, manufacturing, and robotics sectors in Massachusetts and operates accelerator programs to support portfolio companies. MassVentures leverages the state's entrepreneurial ecosystem, educated workforce, and centers of innovation to back early-stage ventures.

Atlas Venture is a Cambridge-based venture capital firm with a 30-year history of building life sciences companies. Founded in 1980, it focuses on early-stage opportunities in biotechnology, biopharmaceuticals, diagnostics, medical devices, and related life sciences, as well as technology sectors. The firm uses a seed-led venture creation approach and often leads initial rounds, providing strategic guidance and board representation to portfolio companies. Its portfolio has included the development of more than 25 medicines and the launch of eight startups through its incubator program, and it has facilitated 43 IPOs and 39 M&A exits. Atlas operates with a global reach across the United States and Europe, supporting life science entrepreneurs in translating scientific advances into therapies and commercial opportunities.

Polaris Partners is a venture capital firm based in Boston, Massachusetts, founded in 1996. It invests in technology and life sciences companies across the United States and Europe, supporting multiple stages from early development to growth. Its portfolio spans software, healthcare information technology, digital health, biotechnology, pharmaceuticals, and related life sciences, with emphasis on molecules, platforms, therapeutics, genomics, and data-driven healthcare solutions. The firm maintains a presence in Boston and San Francisco and emphasizes deep engagement with founders, offering strategic guidance and network resources to accelerate growth.

Morningside Group is a venture capital firm founded in 1986, originally established as a family office for the Chan family, and is based in the greater Boston area. The firm makes venture investments in companies with novel science and technology, pursuing a long-term, patient approach to company-building and emphasizing ethical practices. Its investment focus spans life sciences, digital health, artificial intelligence, materials science, and information technology. In addition to its investment activities, Morningside supports charitable initiatives in education, research, and healthcare, with partnerships including the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

General Catalyst is a venture capital firm that provides early-stage and growth equity investments in technology companies. Founded in 2000 and based in the United States, the firm backs startups across consumer, enterprise software, fintech, crypto, and health technologies, offering mentorship and strategic guidance to help ideas scale. It participates in seed and growth rounds, often taking minority or majority stakes, and supports portfolio companies with resources and networks across North America and Europe.

Alumni Ventures is a venture capital firm founded in 2014 and based in Manchester, New Hampshire. It connects accredited individual investors with startup deals and co-invests alongside established venture capital firms across multiple stages, from seed to growth. The firm provides access to diversified portfolios through funds, syndicates, and investing clubs, supported by a large network of community members and individual investors. It invests across sectors and geographies, with a focus on transparency and due diligence in collaborative investments with leading firms such as Andreessen Horowitz, Sequoia, and Y Combinator. Alumni Ventures operates internationally with offices in New York, Boston, Menlo Park, Chicago, London, and Tokyo and has raised substantial capital to back founders with strategic capital and resources.

Founder Collective is a venture capital firm founded in 2009 with offices in Cambridge, Massachusetts and New York. It focuses on seed and early-stage investments across sectors, prioritizing founder alignment and capital efficiency. The firm is built by founders and aims to support entrepreneurs from concept through outcomes, fostering a community of founders and sharing insights through articles and newsletters. While industry-agnostic, it backs technology-driven companies and maintains a globally active investment approach.

Founded in 2000, Flagship Pioneering is a Cambridge, Massachusetts-based venture capital firm that conceives, creates, resources, and grows first-in-category companies in health technology, biotechnology, life sciences, and related fields. It accelerates advances in biology, engineering, medicine, energy, and beyond by combining scientific innovation with entrepreneurial leadership and professional capital management to bring seemingly unreasonable propositions through an evolutionary, company-building process. The firm focuses on developing and supporting early-stage ventures that aim to transform human health and sustainability.

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with a global investment reach. It provides capital and operational support to early, growth, and later-stage companies across a wide range of industries, including software, consumer technology, healthcare technology, life sciences, energy technology, infrastructure, and AI-enabled services. NEA collaborates with founders to address technical challenges, guide product development, and expand markets, leveraging its domain expertise to help portfolio companies scale from seed stages through IPO. The firm invests across the United States, Asia, and other regions, often supporting companies from early stages to scale, and has a long track record that includes numerous IPOs and acquisitions. NEA emphasizes a hands-on partnership approach and seeks opportunities across sectors that enable transformational businesses through technology and data-driven innovation.

Accomplice is a seed-led venture capital firm based in Cambridge, Massachusetts, focused on early-stage technology startups. It specializes in cybersecurity, esports, data analytics, SMB software, emerging hardware platforms, and marketplaces. The firm emphasizes a community-driven approach, leveraging networks such as AngelList to identify and fund founders and supporting them through collaborative programs. While most investments are in the Boston area, Accomplice backs companies across the United States, Canada, and the European Union. Originating as Atlas Venture, the technology group was renamed Accomplice in 2014, establishing a prominent early-stage presence in New England.

ARCH Venture Partners is a Chicago-based venture capital firm founded in 1986 that concentrates on science-driven startups, especially in life sciences, biotechnology, healthcare, and related technologies. It backs companies co-founded by scientists and entrepreneurs and supports commercialization of innovations developed at academic research institutions and national laboratories. The firm takes a long-term, hands-on approach, leveraging its network to assist portfolio companies from inception to market realization and to build transformative enterprises. ARCH has raised ten venture funds totaling over $3 billion and has invested in more than 150 companies worldwide, reflecting a focus on strategic value creation and governance.

OrbiMed is a global healthcare investment firm founded in 1989 and based in New York, with a worldwide presence that includes offices in several regions. It allocates capital across private equity, venture capital, and public equity to support healthcare companies at various stages, from startups to established firms. Its focus spans biopharmaceuticals, medical devices, diagnostics, life sciences tools, and digital health, as well as healthcare services. The firm pursues opportunities across major markets in North America, Europe, and Asia, often leveraging region-specific teams to invest in companies in Israel, China, India, South Korea, and other jurisdictions. OrbiMed emphasizes building world-class companies by providing strategic financing, industry expertise, and global resources to portfolio companies in pursuit of medical breakthroughs and sustainable growth.

Mission BioCapital is a life sciences venture capital firm established in 2009 and based in Cambridge, Massachusetts, that funds early-stage biotechnology companies and supports them through clinical development. The firm emphasizes mentorship and practical assistance, offering entrepreneurs access to laboratory space, incubator networks, and programs designed to accelerate progress and secure follow-on funding. Its approach combines capital with hands-on guidance across discovery, development, and commercialization, leveraging a history of supporting dozens of startups. Through a broad ecosystem in the United States and Europe, Mission BioCapital aims to translate scientific discoveries into tangible solutions by pairing funding with operational support, expert advice in areas such as drug discovery, legal, and accounting, and strategic mentorship to help portfolio companies reach milestones and attract subsequent investment.

F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts, with a long history of investing in healthcare and technology companies. It backs early-stage and growth companies across life sciences, including therapeutics, medtech, and healthtech, and technology sectors such as enterprise software, fintech, frontier tech, and crypto, with a global reach across the Americas, Europe, and Asia. The firm manages about 4.8 billion in capital and relies on a multidisciplinary team of scientists, engineers, physicians, operators, and investors to help portfolio companies accelerate scalable growth. It also provides advisory support, leveraging deep sector expertise and operational experience to guide portfolio companies toward meaningful breakthroughs.

Spark Capital is an early-stage venture capital firm based in San Francisco with offices in Boston and New York City. It backs founders developing innovative products across all sectors and stages, guiding them to achieve success on their own terms. The firm has funded notable companies including Twitter, Discord, Anthropic, Cruise, Niantic, Oculus, Warby Parker and Tumblr, illustrating its willingness to back consumer, software, and technology leaders. Spark Capital emphasizes flexibility over prescriptive playbooks, supporting entrepreneurs from seed through growth rounds, and partners with portfolio companies to help scale products and go-to-market strategies while spanning sectors such as consumer, software, fintech, media, and education.

Matrix Partners is a venture capital firm founded in 1977 and based in San Francisco that funds early-stage technology companies. The firm focuses on applied AI, B2B software, fintech, health tech, infrastructure and hardware, and supports ventures from idea to Series A with a hands-on, founder-friendly approach drawn from its team of former entrepreneurs. It has backed and partnered with companies such as Apple, FedEx, Oculus, Canva, Zendesk and HubSpot, Postmates and Fivetran, illustrating a history of broad technology investments across the United States, China and India. Matrix Partners combines local knowledge with global experience to help portfolio companies scale into category-leading businesses.

Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities. It provides seed through growth capital to life science and technology companies developing breakthrough therapies, diagnostics, research tools, agrifoodtech, agtech, digital health, and related platforms. Backed by the parent company’s industry experience and scientific advisory network, the firm leverages long-standing relationships and domain expertise to support early to growth-stage ventures aiming to translate scientific advances into practical healthcare and technology solutions.

North Bridge Venture Partners is a venture capital firm based in Needham, Massachusetts, founded in 1993. It provides seed-to-growth financing to startups in the United States operating in software, open source, cloud computing, e-commerce, big data and analytics, and mobile technologies, among others, helping transform ideas into market-leading businesses.

Casdin Capital is an investment firm focused on life sciences and healthcare. Founded in 2012 by Eli Casdin and based in New York, it seeks opportunities across the life sciences spectrum, including biotechnology, digital health, oncology, agtech, and healthcare services. The firm pursues early- to late-stage private investments and, at times, long-short equity strategies, leveraging data-driven insights, molecular information, and precision medicine to identify transformative opportunities. It emphasizes patient capital, disciplined investing, and strong collaborations to support companies advancing diagnostics, therapeutics, and sustainable solutions. By capturing and processing data to unlock breakthroughs, Casdin Capital backs teams with the potential to transform modern medicine.

Invus is a private investment firm founded in 1985 and based in New York with a global footprint. It partners with entrepreneurs and owner-managers to drive transformative growth through flexible, long-term capital and customized investment approaches. The firm aligns its incentives with management and pursues opportunities across private equity and selective co-investments, leveraging an evergreen capital base to support portfolio companies through bumps and cycles. Invus operates globally with offices in New York, London, Paris, and Hong Kong and focuses on companies with competitive advantages in consumer, technology, and life sciences sectors, among others.

Eli Lilly and Company is a global biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing medicines across neuroscience, cardiometabolic, cancer, and immunology. The company operates manufacturing and distribution facilities in the United States, Puerto Rico, and multiple countries, with products sold in about 135 markets worldwide. Through ongoing research and development, Lilly aims to deliver therapies that improve patient outcomes and access to medicines. Its portfolio includes treatments such as Mounjaro and Jardiance for cardiometabolic diseases, Verzenio and Jaypirca for cancer, Trulicity and Humalog for diabetes, and Taltz and Olumiant for immunology, among others. Lilly emphasizes safety and quality in manufacturing and supports patients through educational and support initiatives, reflecting a long history of pharmaceutical leadership and a commitment to advancing personalized medicine.

Insight Partners is a global private equity and venture capital firm that partners with growth-stage software, internet, and data-services companies to accelerate revenue growth and long-term value. Founded in 1995 and headquartered in New York, it focuses on software-enabled sectors including Fintech, Cybersecurity, AI/ML, DevOps, and Healthcare, and has backed more than 750 companies worldwide, with numerous portfolio companies achieving IPOs. The firm provides capital, hands-on operational guidance, and a broad network to help growing software companies move from product-market fit to IPO, assisting with product development, M&A, efficiency, and geographic expansion. As of 2022, Insight Partners reported over 75 billion in assets under management and maintains offices in New York, London, Tel Aviv, and Palo Alto to support its global portfolio.

.406 Ventures is a Boston-based venture capital firm that backs early-stage information technology and services companies, with emphasis on IT security and infrastructure, cloud and data, SaaS, cybersecurity, digital health, AI, fintech, and healthcare IT. It typically serves as lead investor in seed and Series A rounds, with initial investments of 2 to 5 million and total commitments around 6 to 10 million per company, and pursues board representation. The firm concentrates on the Northeast United States and leverages a veteran team of entrepreneurs and operators to provide strategic guidance, networks, and hands-on support to help portfolio companies grow and scale.

Khosla Ventures is a California-based venture capital firm founded in 2004 and headquartered in Menlo Park. It provides capital and strategic guidance to technology companies across stages, investing in sectors including artificial intelligence, digital health, sustainability, climate tech, and consumer technology. The firm seeks startups with innovative technologies or business models and offers hands-on support to help build enduring companies. It manages multiple funds and runs initiatives such as Khosla Impact, which supports high-impact for-profit ventures addressing the needs of low-income populations and emerging markets. Through funding and guidance, it backs transformative technologies and scalable businesses in the United States and globally.

Pillar VC is a Boston-based venture capital firm founded in 2016 that invests in early-stage technology startups. The firm backs a broad portfolio spanning machine intelligence, AI, hardware, enterprise software, blockchain, quantum computing, digital health, and synthetic biology, with a focus on supporting founders from inception. Pillar VC provides first capital and helps founders grow through connections, coaching, and a supportive community. It partners with university spinouts led by first-time founders as well as serial entrepreneurs, aiming to back the next generation of impactful companies in Boston.

SV Health Investors is a global healthcare-focused private equity and venture capital firm that backs therapeutics, biotech, medtech, and other life sciences opportunities across the United States and Europe. Founded in 1993 and headquartered in Boston, with offices in San Francisco and London, the firm supports investments across development stages and seeks to build breakthrough medicines, devices, and related technologies. With a multi-decade track record, SV Health Investors aims to create value for patients and investors through strategic partnerships, growth-led funding, and successful exits.

Hyperplane Venture Capital is a Boston-based early-stage venture capital firm that focuses on technology companies, particularly those applying machine intelligence, data analysis, and related innovations. Founded in the mid-2010s in Boston, the firm partners with exceptional founders leveraging machine intelligence, sensor technology, and cloud computing to solve complex problems and build software and data-driven businesses, with emphasis on perception, communication, intelligence, and insight. The firm concentrates on software and business products and services, especially B2B opportunities, and backs early-stage ventures in areas such as artificial intelligence, machine learning, distributed systems, automation, cloud computing, robotics, and related sectors.

Launchpad Venture Group is a Boston-based angel investment group and venture capital firm focused on funding early-stage technology and life science companies in the United States, with a particular emphasis on New England. It provides both financial capital and human capital—mentorship, guidance, and investment acumen—to startups addressing innovative, tech- and science-driven opportunities. The firm supports a broad range of sectors including software, information technology, web and mobile, e-commerce, media and social platforms, medical devices, diagnostics, healthcare IT, networking and telecom, and cleantech. It promotes a culture of learning and service, facilitating streamlined deal evaluation and active engagement with portfolio companies. Annual activity includes multiple rounds totaling several million dollars, illustrating a hands-on approach to helping entrepreneurs grow sustainable businesses.

Third Rock Ventures is a Boston-based venture capital firm focused on life sciences and healthcare. The firm invests in start-up and early-stage companies across biotechnology, pharmaceuticals, medical devices, diagnostics, therapeutics, and related information technologies, seeking to build companies with the potential to transform patient care. It typically leads initial investments and pursues strategic collaborations to accelerate development, while taking an active role in portfolio companies through management and governance involvement. The firm emphasizes bold science and disruptive approaches, including oncology, cardiovascular devices, and AI-enabled or data-driven healthcare solutions. Founded in 2007, Third Rock maintains a U.S.-centred portfolio with offices in San Francisco, and collaborates with larger pharmaceutical and biotechnology partners to advance products from discovery to market.

Northpond Ventures is a science-driven venture capital firm specializing in growth capital, headquartered in Bethesda, Maryland, with offices in San Francisco, California, and Cambridge, Massachusetts. Founded in 2018, it focuses on life sciences and technology sectors, including diagnostics, digital health, health tech, therapeutics, and artificial intelligence and machine learning. The firm backs growth-stage companies advancing biomedical research and technology-enabled healthcare, aiming to translate scientific advances into commercial solutions.

Beacon Angels is a Boston-based angel investment group established in 2006 that backs early-stage and fast-growing companies in New England. The group typically provides capital in the range of $100,000 to $300,000 to support growth, product development, and market expansion.

Deerfield Management is a New York-based healthcare investment firm focused on long-term, structured investments in public and private healthcare companies. Founded in 1994, it manages a diversified portfolio spanning therapeutics, medical devices, diagnostics, digital health, and health services. The company combines investment activity with information services and philanthropy, leveraging Deerfield Intelligence, an approach that uses AI, data, and market research to inform decisions. It supports innovation through initiatives such as Deerfield Discovery and Development and the Deerfield Foundation, which aims to improve children's health worldwide. Through its capital and strategic insight, Deerfield seeks to connect capital, ideas, and technology to advance human health.

E14 Fund is a Cambridge, Massachusetts based venture capital firm affiliated with the Massachusetts Institute of Technology. It focuses on seed and early‑stage deep‑tech startups founded or led by MIT alumni, faculty, or students, aiming to move technologies from the lab into commercial use. The firm provides initial funding and, where appropriate, follow‑on investments, and it leverages the MIT ecosystem, its network of investors, industry experts, and entrepreneurs to help portfolio companies scale, raise capital, and commercialize innovations. The investment scope covers sectors including artificial intelligence and computing, hardware and robotics, physics and materials science, biology, and other deep‑tech fields. The firm emphasizes building a diverse portfolio and notes the involvement of founders from outside the United States.

Underscore VC is a Boston-based venture capital firm that backs early-stage technology startups across the United States, from pre-seed to Series A. The firm concentrates on enterprise software and B2B applications, with interests in artificial intelligence and machine learning, vertical SaaS, fintech, insurtech, healthtech, e-commerce, and related cloud and data infrastructure. It targets companies leveraging cloud platforms, data storage, and software for industries such as manufacturing, home automation, and healthcare, and seeks opportunities in infrastructure and cloud-enabled solutions for marketing and commerce. Underscore VC emphasizes an open, collaborative approach, leveraging a Core Community of founders and executives to align incentives with portfolio companies and provide guidance. Based in Boston, the firm aims to connect startups with the region’s innovation ecosystem while applying a broad U.S. footprint to identify ambitious teams and scalable technology businesses.

Novo Nordisk is a global healthcare company focused on discovering, developing, and delivering medicines for chronic diseases, with insulin and diabetes care at its core. It develops and distributes insulin and other diabetes therapies, and invests heavily in scientific research and biotechnology to advance breakthroughs. The company operates worldwide, aiming to expand access to its treatments and improve patient outcomes, while emphasizing sustainability, partnerships, and social responsibility.

SOSV is a global venture capital firm founded in 1995 and headquartered in New Jersey. The firm focuses on seed-to-growth investments in deep tech sectors, including biotech and life sciences, hardware and robotics, and cross-border software with emphasis on markets in Asia. It supports startups from early stages with investment capital as well as resources such as laboratories, collaborative spaces, and expert mentorship to accelerate product development and market traction. SOSV operates purpose-built programs to help portfolio companies raise follow-on funding, scale operations, and reach customers, often through structured matchmaking and access to a global network of investors. With a broad portfolio spanning hundreds of companies worldwide, SOSV aims to foster innovation, build vibrant entrepreneurial ecosystems, and contribute to sustainable technological advancement.

Bessemer Venture Partners is a global venture capital firm based in Redwood City, California. It backs entrepreneurs across seed and growth stages and invests across consumer, enterprise and healthcare sectors. The firm has backed notable companies such as Pinterest, Shopify, Twilio, Yelp, LinkedIn, PagerDuty, DocuSign, Wix, Fiverr and Toast, and it has about $19 billion in assets under management.

Venrock is a venture capital firm founded in 1969 as the venture capital arm of the Rockefeller family. Based in Palo Alto, California, with offices in New York City, it specializes in seed and early-stage investments across technology and healthcare, including information technology, software, cybersecurity, genomics, and digital health. The firm supports entrepreneurs with capital, strategic guidance, and access to its network to help build enduring companies. Notable portfolio entries include Apple, Illumina, Gilead Sciences, Intel, Nest, Endeca, and SlideShare, reflecting a history of backing influential technology and life sciences ventures.

CVP Management is a venture capital firm focused on early‑stage technology investments, including seed and early Series A rounds. It concentrates on information technology infrastructure with emphasis on software applications, internet, digital media, digital marketing, vertical SaaS, cloud, embedded software, mobile, and financial services technologies. The firm typically invests from $0.1 million to $1 million, and for seed and Series A rounds from $1 million to $3.5 million, in companies with an enterprise value around $5 million. It prefers to hold a seat on the portfolio company board and to invest in preferred stock. The firm funds companies located in the Northeast corridor, especially Boston, New York, and Toronto, and began operation on June 1, 1998, with headquarters in Cambridge, Massachusetts, and an additional office in Boston.

LaunchCapital is a venture capital firm that provides seed and early-stage funding along with hands-on support to ambitious entrepreneurs. Established in 2008 and based in New Haven, Connecticut, it partners with founders to build scalable companies across diverse sectors including commerce, marketplace, consumer, media and entertainment, enterprise software and services, emerging technology, data, finance, healthcare, and medical technology. The firm emphasizes a long-term partnership, capital efficiency, and access to a network of entrepreneurs, advisory services, and accelerators to facilitate sustainable growth and prepare companies for future venture rounds.

Samsara BioCapital is a venture capital firm based in Palo Alto, California, that invests in biotechnology and healthcare companies across the United States. The firm supports biotech ventures by providing capital and strategic guidance to help advance innovative therapies and discoveries. It operates as a registered investment adviser, offering investment advisory services to entrepreneurs and venture teams as they work to bring new biotech solutions to market.

Boston Seed Capital is a venture capital firm headquartered in the Boston area, with an office in Wellesley Hills, Massachusetts. Founded in 2010, it focuses on seed and early-stage investments in internet-enabled and technology-driven companies, including information technology, SaaS, cybersecurity, e-commerce, big data, marketplaces, esports, artificial intelligence and machine learning, as well as consumer goods and business services. The firm backs ventures across the United States, supporting early growth opportunities in consumer and technology sectors.

Highland Europe is a venture capital firm based in London, United Kingdom. It focuses on growth-stage investments in consumer and enterprise technology companies across Europe and Israel, including internet, mobile and software sectors. The firm backs rapidly growing firms with equity capital and can provide acquisition finance or lead secondary transactions as well as primary investments. Founded in 2012, Highland Europe aims to help management teams accelerate growth and build durable businesses.

Refactor Capital is a venture capital firm based in Burlingame, California, founded in 2016. It concentrates on seed- and early-stage investments in hard technology, biotechnology, and health, with a breadth of sectors including energy, earth systems, aerospace, manufacturing, and critical materials. The firm is led by Zal Bilimoria as sole general partner.

NextView Ventures is a seed and early-stage venture capital firm based in the United States with offices in New York, San Francisco, and Boston. Founded in 2010, it pursues a high-conviction, hands-on approach to backing entrepreneurs building companies across North America, with a focus on software, fintech, health, consumer, ecommerce, and B2B technologies. The firm emphasizes thematic investing and provides portfolio companies with resources, guidance, and founder-oriented programs to help teams scale. It maintains active involvement in its companies, occasionally taking board or observer seats, and seeks to partner with founders to create companies of lasting impact. NextView aims to foster growth within a broader ecosystem, supporting companies from pre-seed through early stages and helping them reach scalable, durable success.

Clean Energy Ventures is a venture capital firm focused on accelerating climate technology startups at seed and early stages. Based in Boston, Massachusetts, it backs companies developing advanced energy technologies and innovative business models to reduce greenhouse gas emissions. The firm invests in sectors such as energy storage, grid connectivity, renewable energy, clean transportation and related water and energy nexus initiatives, with a geographic focus on the United States and Canada and a broader reach into Europe and Israel. It complements capital with mentorship, strategic guidance and access to a wide network of industry experts to help portfolio companies scale and deploy transformative clean energy solutions.

CRV is a Palo Alto–headquartered venture capital firm founded in 1970. It is one of the oldest active early-stage VC firms and invests from seed to Series B in technology, consumer, and healthcare companies, including life sciences and bioengineering, across North America. The firm uses a hands-on, value-added approach to support portfolio companies and help entrepreneurs build category-leading firms in high-growth technology and media sectors. CRV maintains offices in Cambridge, Massachusetts, and Menlo Park, California, and manages roughly $1.5 billion. It has backed notable companies such as Twitter, Zendesk, Amgen, HubSpot, Yammer, EqualLogic, Sonus Networks, and Parametric Technology.

Lightspeed Venture Partners is a global venture capital firm founded in 2000 and based in Menlo Park, California. It invests across the startup lifecycle, from seed to growth, in sectors including enterprise technology, consumer, fintech, health, and cleantech, with a focus on software, internet, mobile, and other technology-enabled businesses. The firm operates internationally with offices in Beijing, Shanghai, New Delhi, and Herzliya Pituach, enabling it to back entrepreneurs across the United States, Asia, and Israel.

Omega Funds is a Boston-based venture capital firm founded in 2004 that focuses on funding early-stage healthcare and biotechnology companies in North America and Western Europe. The firm backs ventures across life sciences, digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and software-as-a-service, seeking to advance therapies, platforms, and digital health solutions. With a seasoned team and extensive industry network, Omega Funds collaborates with exceptional founders to improve clinical and commercial success in the healthcare sector.